8/4/2010: Hello everyone, I am Dr. Muin Khoury, director of the Office of Public Health Genomics at the Centers for Disease Control and Prevention. You may have heard about different tests. You may even have had patients ask you about these tests or share the results with you. So why aren't personal genomic tests ready for primetime? There are 3 key factors that must be considered in the development and evaluation of genetic tests in clinical practice. First, there is the test's analytic validity, which is the test's ability to accurately and reliably measure the thousands of genetic variants on these tests. In many cases, personal genomic tests do meet quality standards for laboratories. The second thing we have to look at is the clinical validity of these tests, which is the ability of the test to detect or predict particular diseases and health conditions. This is the area for which the data are in so much flux right now. Most common diseases, as ...
HNPCC is a heredity form of Colon Cancer that can be passed through generations of family undetected.